Close Search
JDDonline - Journal of Drugs in Dermatology
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Acne
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In
  • x-twitter facebook linkedin instagram
May 16
Love0

Diacerein 1% Ointment for the Treatment of Epidermolysis Bullosa Simplex: A Randomized, Controlled Trial

By Chuck Lin No Comments
INTRODUCTIONEpidermolysis bullosa simplex (EBS), the most common type of epidermolysis bullosa, is a rare genetic skin condition, diagnosed in approximately 8 per 1 million births.1 Characterized by mechanical fragility and…
Read More
May 10
Love0

Increased Doses of Adalimumab are Associated With Clinical Improvement of Hidradenitis Suppurativa

By Chuck Lin No Comments
INTRODUCTIONHidradenitis suppurativa (HS) is a debilitating chronic inflammatory disease with a single approved treatment, TNF-antagonist adalimumab 40 mg/week (ADA40). However, only half of patients treated with ADA40 achieved Hidradenitis Suppurativa…
Read More
May 10
Love0

Placement of High Dose Neurotoxins for Treatment-Resistant Rosacea

By Chuck Lin No Comments
INTRODUCTIONRosacea is a chronic inflammatory skin condition characterized by facial erythema, telangiectasias, and papulopustular lesions, reported in as high as 22% of the population.1,2 Most patients are diagnosed after the…
Read More
May 10
Love0

Topical Application of 0.5% Timolol Maleate Hydrogel for the Treatment of Superficial Infantile Hemangiomas

By Chuck Lin No Comments
INTRODUCTIONInfantile hemangiomas (IHs) are a common childhood tumor occurring in 5-10% of children and present as selflimiting vascular endothelial tumors, often involving the head and neck.1 Present at birth followed…
Read More
May 09
Love0

Role of Retinoic Acid Receptor Subtypes in the Pathophysiology of Acne

By Chuck Lin No Comments
INTRODUCTIONTopical retinoids are used for a number of dermatological conditions including psoriasis, pigmentary disorders, and skin cancers and are well-established acne treatments.1 These are agonists of retinoic acid receptors (RAR),…
Read More
May 05
Love0

Unmet Needs in the Management of Acne Vulgaris: A Consensus Statement

By Chuck Lin No Comments
INTRODUCTIONThe most recent American Academy of Dermatology (AAD) guidelines on acne treatment were published in 2016.1 The Acne Management Consensus Roundtable, a group of dermatologists, was convened in 2022 to…
Read More
Apr 28
Love0

Allergens in Common Brands of Clobetasol

By Chuck Lin No Comments
INTRODUCTIONTopical corticosteroids are one of the most commonly prescribed medications by dermatologists.1 Allergic contact dermatitis (ACD) to topical corticosteroids has been widely recognized since the late 1980s.2 Allergy to corticosteroids…
Read More
Apr 28
Love0

Diversifying the Mohs Workforce: Understanding Barriers of Applicants to Mohs Micrographic Surgery Fellowship

By Chuck Lin No Comments
INTRODUCTIONThe population of the United States is becoming increasingly diverse. Dermatology lags, particularly amongst Mohs micrographic surgeons, where less than 4.5% identify as underrepresented in medicine (URM).1 It is important…
Read More
Apr 28
Love0

Non-Invasive Treatment of Basal Cell Carcinoma: Photodynamic Therapy Following Curettage

By Chuck Lin No Comments
INTRODUCTIONBasal cell carcinoma (BCC) is the most common form of skin cancer in North America.1,2 Although there is a 5-year survival rate of 100% and metastasis is rare (incidence of…
Read More
Apr 28
Love0

Keratinocyte Carcinoma Chemoprevention With a Combination of Imiquimod, 5-Fluorouracil, and Tretinoin

By Chuck Lin No Comments
INTRODUCTIONKeratinocyte carcinomas (KCs), comprising basal cell carcinomas (BCCs) and squamous cell carcinomas (SCCs), are the most frequently occurring human malignancies. Cure rates are high, but the incidence of KCs is…
Read More
Apr 27
Love0

FULL SUPPLEMENT: Environmental Aggressors And Comprehensive Protection: Chelating Agents In Skincare

By Chuck Lin No Comments
In this supplement: Chelating Agents in Skincare: Comprehensive Protection Against Environmental AggressorsIn addition to ultraviolet light, skin is regularly exposed to several environmental stressors that can cause damage and premature…
Read More
Apr 27
Love0

Supplement Individual Article: Chelating Agents in Skincare: Comprehensive Protection Against Environmental Aggressors

By Chuck Lin No Comments
INTRODUCTIONAlthough the importance of protecting the skin from sunlight is widely recognized, ultraviolet (UV) light is the main cause of skin damage and premature aging. However, many other outdoor stressors…
Read More
« Previous
NextPrevious »

Search page

Advertisement

Popular

  • JDD Interview with Dr. Christopher Bunick: An In-Depth Interview Focusing on Atopic Dermatitis and the LEVEL UP Period 2 Data September 12, 2025
  • Oral Hyaluronic Acid Supplement: Efficacy in Skin Hydration, Elasticity, and Wrinkle Depth Reduction September 12, 2025
  • JDD September Highlights and Editor Picks September 11, 2025
  • Podcasting on Podcasts: Dr. Adam Friedman and Dr. Jim Del Rosso Unpack the Mics September 10, 2025
  • A Pilot Study Evaluating Efficacy of a Topical Klotho Anti-Aging Serum to Treatable Visible Photoaging September 10, 2025

Advertisement

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
CONTACT US     |      FEEDBACK    |      TERMS     |      COOKIE POLICY    |     PRIVACY    |      EDITORIAL POLICY    |     ADVERTISING POLICY  |    MANAGE PREFERENCES  |  YOUR PRIVACY CHOICES

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
DermAtlas        Derm In-Review         PDE        Next Steps in Derm         Skin of Color Update     ODAC Dermatology, Aesthetic & Surgical Conference

Journal of Drugs in Dermatology

  • About Us
  • Contact Us
  • Contact Sales
  • Editorial Board
  • eJDD
  • Institutional, Library, & Corporate Subscriptions
  • Log In
  • Open Access
  • Permissions Request
  • Podcast Sponsorship
  • Subscription Info
  • Store

© 2025 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.

  • twitter
  • facebook
  • linkedin
  • instagram
Close Menu
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Acne
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In

Search